References | Journal | Year | |
Performance of plasma p-tau217 for the detection of amyloid-β positivity in a memory clinic cohort using an electrochemiluminescence immunoassay Adam H. Dyer, Helena Dolphin, Antoinette O’Connor, Laura Morrison, Gavin Sedgwick, Conor Young, Emily Killeen, Conal Gallagher, Aoife McFeely, Eimear Connolly, Naomi Davey, Paul Claffey, Paddy Doyle, Shane Lyons, Christine Gaffney, Ruth Ennis, Cathy McHale, Jasmine Joseph, Graham Knight, Emmet Kelly, Cliona O’Farrelly, Aoife Fallon, Sean O’Dowd, Nollaig M. Bourke & Sean P. Kennelly | Biomedcentral | 2024 | View |
Toward a human brain extracellular vesicle atlas: Characteristics of extracellular vesicles from different brain regions, including small RNA and protein profiles Yiyao Huang, Tanina Arab, Ashley E. Russell, Emily R. Mallick, Rajini Nagaraj, Evan Gizzie, Javier Redding-Ochoa, Juan C. Troncoso, Olga Pletnikova, Andrey Turchinovich, David A. Routenberg, Kenneth W. Witwer | Interdisciplinary Medicine | 2023 | View |
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome Lawren VandeVrede, Renaud La Joie, Elisabeth H Thijssen, Breton M Asken, Stephanie A Vento, Torie Tsuei, Suzanne L Baker, Yann Cobigo, Corrina Fonseca, Hilary W Heuer, Joel H Kramer, Peter A Ljubenkov, Gil D Rabinovici, Julio C Rojas, Howie J Rosen, Adam M Staffaroni, Brad F Boeve, Brad C Dickerson, Murray Grossman, Edward D Huey, David J Irwin, Irene Litvan, Alexander Y Pantelyat, Maria Carmela Tartaglia, Jeffrey L Dage, Adam L Boxer | JAMA Neurology | 2023 | View |
Plasma biomarkers for diagnosis of Alzheimer’s disease and prediction of cognitive decline in individuals with mild cognitive impairment Pia Kivisäkk, Thadryan Sweeney, Becky C. Carlyle, Bianca A. Trombetta, Kathryn LaCasse, Leena El-Mufti, Idil Tuncali, Lori B. Chibnik, Sudeshna Das, Clemens R. Scherzer, Keith A. Johnson, Bradford C. Dickerson, Teresa Gomez-Isla, Deborah Blacker, Derek H. Oakley, Matthew P. Frosch, Bradley T. Hyman, Anahit Aghvanyan, Pradeepthi Bathala, Christopher Campbell, George Sigal, Martin Stengelin, Steven E. Arnold | Frontiers in Neurology | 2023 | View |
Quantitation of neurofilament light chain protein in serum and cerebrospinal fluid from patients with multiple sclerosis using the MSD R-PLEX NfL assay Antigona Ulndreaj, Dorsa Sohaei, Simon Thebault, Oscar D Pons-Belda, Amaia Fernandez-Uriarte, Christopher Campbell, David Cheo, Martin Stengelin, George Sigal, Mark S Freedman, Isobel A Scarisbrick, Ioannis Prassas, Eleftherios P Diamandis | Diagnosis | 2023 | View |
Lecanemab in Early Alzheimer's Disease Christopher H van Dyck, Chad J Swanson, Paul Aisen, Randall J Bateman, Christopher Chen, Michelle Gee, Michio Kanekiyo, David Li, Larisa Reyderman, Sharon Cohen, Lutz Froelich, Sadao Katayama, Marwan Sabbagh, Bruno Vellas, David Watson, Shobha Dhadda, Michael Irizarry, Lynn D Kramer, Takeshi Iwatsubo | The New England Journal of Medicine | 2023 | View |
Elevation of neural injury markers in patients with neurologic sequelae after hospitalization for SARS-CoV-2 infection Michail Spanos, Sigal Shachar, Thadryan Sweeney, H Immo Lehmann, Priyanka Gokulnath, Guoping Li, George B Sigal, Rajini Nagaraj, Pradeepthi Bathala, Farhan Rana, Ravi V Shah, David A Routenberg, Saumya Das | iScience | 2022 | View |
Associations between prognostic index scores and plasma neurofilament light in Huntington's disease Georgia M Parkin, Jody Corey-Bloom, Jeffrey D Long, Chase Snell, Haileigh Smith, Elizabeth A Thomas | Parkinsonism & Related Disorders | 2022 | View |
Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations Bing Sun, Norina Tang, Michael J. Peluso, Nikita S. Iyer, Leonel Torres, Joanna L. Donatelli, Sadie E. Munter, Christopher C. Nixon, Rachel L. Rutishauser, Isabel Rodriguez-Barraquer, Bryan Greenhouse, John D. Kelly, Jeffrey N. Martin, Steven G. Deeks, Timothy J. Henrich, and Lynn Pulliam | Cells | 2021 | View |
Leptin levels are associated with multiple sclerosis risk Biström M, Hultdin J, Andersen O, Alonso-Magdalena L, Jons D, Gunnarsson M, Vrethem M, Sundström P | Multiple Sclerosis | 2020 | View |
Early and late effects of maternal experience on hippocampal neurogenesis, microglia, and the circulating cytokine milieu Rand S. Eid, Jessica A. Chaiton, Stephanie E. Lieblich, Tamara S. Bodnar, Joanne Weinberg, Liisa A.M. Galea | Neurobiology of Aging | 2019 | View |
Altered maternal immune networks are associated with adverse child neurodevelopment: Impact of alcohol consumption during pregnancy Tamara S. Bodnar, Charlis Raineki, Wladimir Wertelecki, Lyubov Yevtushok, Larisa Plotka, Natalya Zymak-Zakutnya, Gordon Honerkamp-Smith, Alan Wells, Matthieu Rolland, Todd S. Woodward, Claire D. Coles, Julie A. Kable, Christina D. Chambers, Joanne Weinberg, and Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD) | Brain, Behavior, and Immunity | 2019 | View |
CCL11 is increased in the CNS in chronic traumatic encephalopathy but not in Alzheimer’s disease Jonathan D. Cherry , Thor D. Stein, Yorghos Tripodis, Victor E. Alvarez, Bertrand R. Huber, Rhoda Au, Patrick T. Kiernan, Daniel H. Daneshvar, Jesse Mez, Todd M. Solomon, Michael L. Alosco, Ann C. McKee | PLOS ONE | 2017 | View |
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration. Toombs J, Foiani MS, Paterson RW, Heslegrave A, Wray S, Schott JM, Fox NC, Lunn MP, Blennow K, Zetterberg H. | J Alzheimers Dis. | 2017 | View |
Inflammation in schizophrenia: cytokine levels and their relationships to demographic and clinical variables. Lee EE, Hong S, Martin AS, Eyler LT, Jeste DV. | Am J Geriatr Psychiatry. | 2017 | View |
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration. Höglund K, Kern S, Zettergren A, Börjesson-Hansson A, Zetterberg H, Skoog I, Blennow K. | Translational Psychiatry | 2017 | View |
Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M, Vernon AC, Benke D, Pomper MG, Sawa A, Meyer U. | Mol Psychiatry. | 2017 | View |
Ablation of Prion Protein in Wild Type Human Amyloid Precursor Protein (APP) Transgenic Mice Does Not Alter The Proteolysis of APP, Levels of Amyloid-β or Pathologic Phenotype. Whitehouse IJ, Brown D, Baybutt H, Diack AB, Kellett KA, Piccardo P, Manson JC, Hooper NM. | PLoS One. | 2016 | View |
Abnormalities in chemokine levels in schizophrenia and their clinical correlates. Hong S, Lee EE, Martin AS, Soontornniyomkij B, Soontornniyomkij V, Achim CL, Reuter C, Irwin MR, Eyler LT, Jeste DV. | Schizophr Res. | 2016 | View |
Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease. Harach T, Jammes F, Muller C, Duthilleul N, Cheatham V, Zufferey V, Cheatham D, Lukasheva YA, Lasser T, Bolmont T. | Neurobiol Aging. | 2016 | View |
Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease. Steen Jensen C, Portelius E, Siersma V, Høgh P, Wermuth L, Blennow K, Zetterberg H, Waldemar G, Gregers Hasselbalch S, Hviid Simonsen A. | Dement Geriatr Cogn Disord. | 2016 | View |
CSF Aβ1-42 - an excellent but complicated Alzheimer's biomarker - a route to standardisation. Kuhlmann J, Andreasson U, Pannee J, Bjerke M, Portelius E, Leinenbach A, Bittner T, Korecka M, Jenkins RG, Vanderstichele H, Stoops E, Lewczuk P, Shaw LM, Zegers I, Schimmel H, Zetterberg H, Blennow K; IFCC Working Group on Standardization of CSF proteins (WG-CSF). | Clin Chim Acta. | 2016 | View |
Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder? Föcking M, Dicker P, Lopez LM, et al. | BMC Psychiatry. | 2016 | View |
Gray matter regions statistically mediating the cross-sectional association of eotaxin and set-shifting among older adults with major depressive disorder. Smagula SF, Karim HT, Lenze EJ, Butters MA, Wu GF, Mulsant BH, Reynolds CF 3rd, Aizenstein HJ. | Int J Geriatr Psychiatry. | 2016 | View |
Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition. Schelle J, Häsler L, Göpfert JC, Joos TO, Vanderstichele H, Stoops E, Mandelkow EM, Neumann U, Shimshek DR, Staufenbiel M, Jucker M, Kaeser SA. | Alzheimers Dement. | 2016 | View |